Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Recurrent Breast Cancer|Stage IV Breast Cancer
Interventions: DRUG: sorafenib tosylate|DRUG: anastrozole
Sponsor: National Cancer Institute (NCI)